Siddharth Mittal steps in as Managing Director & CEO of Syngene International

Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), has announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.

Mittal succeeds Peter Bains, who completed his tenure as Managing Director & CEO on 30 June 2026, bringing close to three decades of business leadership experience. He joins Syngene from Biocon Limited, where he most recently served as the Managing Director and Chief Executive Officer.

During his thirteen years at Biocon, Mittal held the position of Chief Financial Officer, before being appointed Managing Director and CEO. During this period, he played a pivotal role in shaping the strategic direction of the company that positioned it for long term growth, strengthening its commercial operations, expanding its presence across global markets, securing key regulatory approvals and successfully commercializing Biocon's GLP-1 portfolio across major international markets.

He also led strategic partnerships and commercial initiatives that strengthened Biocon's competitive position while driving operational excellence, customer-centricity and sustainable business growth.